Nuclear medicine

Last revised by Francesco Sciacca on 4 Jan 2023

Nuclear medicine in vivo is the practice of utilizing small amounts of radioactive substances (unsealed radioactive sources) to diagnose, monitor and treat disease. The utilization of radiopharmaceuticals (radionuclide + pharmaceutical) offers a unique perspective on both disease and cancer treatment. Specifically, only radionuclides that emit γ or β+ radiation find use in nuclear medical imaging. Radionuclides, on the other hand, which are used in therapy emit - as a rule - β- particles.

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.